Their MERSCOPE Platform enables highly accurate and efficient nucleic acid imaging at subcellular resolution, allowing researchers to gain new insights into biological systems related to human health and disease. This technology has broad applications in fields such as oncology, immunology, neuroscience, infectious disease, developmental biology, and drug discovery. Vizgen's patented MERFISH technology is at the core of their tools, enabling massively multiplexed genome-scale imaging. The company, founded in 2019 and based in Cambridge, Massachusetts, is focused on illuminating biology at the cellular and subcellular level to drive discovery and advance human health.